The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs

NCT ID: NCT02406703

Last Updated: 2020-03-11

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 100 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2014-01-31
• Study Completion Date: 2014-05-31

Brief Summary

Background and Objectives Short acting regional anesthetics have already been successfully employed for peripheral nerve blocks in an ambulatory surgery setting. However, the impact on direct and indirect perioperative costs comparing two different short-acting local anesthetics has not been performed, yet.

Methods In an observational study including 50 patients per group, patient undergoing popliteal block with chloroprocaine 3% or mepivacaine 1.5% for ambulatory minor foot surgery were compared. The primary outcome was the saving of both direct and indirect perioperative costs. Secondary outcomes were block success, onset time and block duration, patient satisfaction and unplanned outpatient visits or readmissions after discharge.

Conditions

Impact of Anesthetic Choice on Costs

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: PROSPECTIVE

Study Groups

Chloroprocaine

Patient undergoing popliteal block with chloroprocaine

Chloroprocaine

Intervention Type: DRUG

Mepivacaine

Patient undergoing popliteal block with mepivacaine

Mepivacaine

Intervention Type: DRUG

Interventions

Chloroprocaine

Intervention Type: DRUG

Mepivacaine

Intervention Type: DRUG

Eligibility Criteria

Inclusion Criteria

• ASA I-III scheduled for elective, unilateral, ambulant minor foot surgery (percutaneous hallux valgus correction, osteotomies, tenotomies, mallet and hammer toes correction, screws and/or plaques removal)

Exclusion Criteria

• known allergy to drugs used in the study;
• coagulopathies, known neuropathy;
• pregnancy;
• chronic pain;
• drug or alcohol abuse;
• psychiatric disease or lack of competence affecting compliance and evidence of ongoing sepsis or local skin / subcutaneous tissues infections in the popliteal fossa.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ospedale Regionale Bellinzona e Valli

OTHER

Sponsor Role: lead

Responsible Party

Andrea Saporito

MD

Responsibility Role: PRINCIPAL_INVESTIGATOR

Other Identifiers

BLV07

Identifier Type: -

Identifier Source: org_study_id